MyAverix Finance
SHG · Healthcare
Guobang Pharma Ltd (605507)
Drug Manufacturers - Specialty & Generic
Guobang Pharma Ltd (605507) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $15.00B, P/E ratio is 17.10, net margin is 14.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 605507
Guobang Pharma Ltd (605507) — FAQ
What is Guobang Pharma Ltd's market cap?
Guobang Pharma Ltd (605507) has a reported market cap of $15.00B (data as of 2026-03-29).
What is 605507's P/E ratio?
The price-to-earnings (P/E) ratio for Guobang Pharma Ltd (605507) is 17.10 (data as of 2026-03-29).
Does Guobang Pharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guobang Pharma Ltd (605507). Check the MyAverix Finance app for the latest dividend data.
What sector is Guobang Pharma Ltd in?
Guobang Pharma Ltd (605507) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 605507 listed on?
605507 is listed on SHG.
What is Guobang Pharma Ltd's net margin?
Guobang Pharma Ltd (605507) reports a net margin of 14.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.